C4 Therapeutics, Inc. is represented on a panel to showcase the award-winning wellness program.
Published
Signal category
Presence & Recognition
Quote
“I’m so excited to be on a panel to represent C4 Therapeutics, Inc. and our award winning wellness program!”
— Melissa Epstein|C4 Therapeutics, Inc. team
Company
C4 Therapeutics, Inc.
Clinical-stage biotech company transforming how disease is treated through targeted protein degradation science
- Location
- Watertown, US
- Company size
- 111 employees
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes.